 | • レポートコード：MRC2-11QY11540 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はクッシング病治療のグローバル市場について調査・分析したレポートです。種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別クッシング病治療の競争状況、市場シェア ・世界のクッシング病治療市場：種類別市場規模 2015年-2020年（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド） ・世界のクッシング病治療市場：種類別市場規模予測 2021年-2026年（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド） ・世界のクッシング病治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局） ・世界のクッシング病治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局） ・北米のクッシング病治療市場分析：米国、カナダ ・ヨーロッパのクッシング病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのクッシング病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のクッシング病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのクッシング病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CORCEPT THERAPEUTICS、HRA Pharma、Strongbridge Biopharma、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands.
Cushing’s disease treatment market revenue is growing with a stable growth rate, this is attributed to increasing number of pipeline drugs. Also increasing interest of pharmaceutical companies to develop Cushing disease drugs is a major factor contributing to the revenue growth of Cushing disease treatment market over the forecast period. Current and emerging players’ focuses on physician education and awareness regarding availability of different drugs for curing Cushing disease, thus increasing the referral speeds, time to diagnosis and volume of diagnosed Cushing disease individuals. Growing healthcare expenditure and increasing awareness regarding Cushing syndrome aids in the revenue growth of Cushing’s disease treatment market. Increasing number of new product launches also drives the market for Cushing’s disease Treatment devices. However availability of alternative therapies for curing Cushing syndrome is expected to hamper the growth of the Cushing’s disease treatment market over the forecast period.
Market Analysis and Insights: Global Cushing’s Disease Treatment Market
The global Cushing’s Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cushing’s Disease Treatment Scope and Market Size
Cushing’s Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cushing’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
CORCEPT THERAPEUTICS
HRA Pharma
Strongbridge Biopharma
Novartis
…
Market segment by Type, the product can be split into
Ketoconazole
Mitotane
Aminoglutethimide
Metyrapone
Mifepristone
Etomidate
Pasireotide
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Clinics
E-Commerce/Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cushing’s Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Cushing’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ketoconazole
1.4.3 Mitotane
1.4.4 Aminoglutethimide
1.4.5 Metyrapone
1.4.6 Mifepristone
1.4.7 Etomidate
1.4.8 Pasireotide
1.5 Market by Application
1.5.1 Global Cushing’s Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Clinics
1.5.6 E-Commerce/Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cushing’s Disease Treatment Market Perspective (2015-2026)
2.2 Global Cushing’s Disease Treatment Growth Trends by Regions
2.2.1 Cushing’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cushing’s Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Cushing’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cushing’s Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Cushing’s Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cushing’s Disease Treatment Players by Market Size
3.1.1 Global Top Cushing’s Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Cushing’s Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Cushing’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cushing’s Disease Treatment Market Concentration Ratio
3.2.1 Global Cushing’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cushing’s Disease Treatment Revenue in 2019
3.3 Cushing’s Disease Treatment Key Players Head office and Area Served
3.4 Key Players Cushing’s Disease Treatment Product Solution and Service
3.5 Date of Enter into Cushing’s Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cushing’s Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Cushing’s Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cushing’s Disease Treatment Market Size by Application (2015-2020)
5.2 Global Cushing’s Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cushing’s Disease Treatment Market Size (2015-2020)
6.2 Cushing’s Disease Treatment Key Players in North America (2019-2020)
6.3 North America Cushing’s Disease Treatment Market Size by Type (2015-2020)
6.4 North America Cushing’s Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cushing’s Disease Treatment Market Size (2015-2020)
7.2 Cushing’s Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Cushing’s Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Cushing’s Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Cushing’s Disease Treatment Market Size (2015-2020)
8.2 Cushing’s Disease Treatment Key Players in China (2019-2020)
8.3 China Cushing’s Disease Treatment Market Size by Type (2015-2020)
8.4 China Cushing’s Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cushing’s Disease Treatment Market Size (2015-2020)
9.2 Cushing’s Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Cushing’s Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Cushing’s Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cushing’s Disease Treatment Market Size (2015-2020)
10.2 Cushing’s Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cushing’s Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Cushing’s Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Cushing’s Disease Treatment Market Size (2015-2020)
11.2 Cushing’s Disease Treatment Key Players in India (2019-2020)
11.3 India Cushing’s Disease Treatment Market Size by Type (2015-2020)
11.4 India Cushing’s Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cushing’s Disease Treatment Market Size (2015-2020)
12.2 Cushing’s Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Cushing’s Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Cushing’s Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 CORCEPT THERAPEUTICS
13.1.1 CORCEPT THERAPEUTICS Company Details
13.1.2 CORCEPT THERAPEUTICS Business Overview
13.1.3 CORCEPT THERAPEUTICS Cushing’s Disease Treatment Introduction
13.1.4 CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2015-2020))
13.1.5 CORCEPT THERAPEUTICS Recent Development
13.2 HRA Pharma
13.2.1 HRA Pharma Company Details
13.2.2 HRA Pharma Business Overview
13.2.3 HRA Pharma Cushing’s Disease Treatment Introduction
13.2.4 HRA Pharma Revenue in Cushing’s Disease Treatment Business (2015-2020)
13.2.5 HRA Pharma Recent Development
13.3 Strongbridge Biopharma
13.3.1 Strongbridge Biopharma Company Details
13.3.2 Strongbridge Biopharma Business Overview
13.3.3 Strongbridge Biopharma Cushing’s Disease Treatment Introduction
13.3.4 Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2015-2020)
13.3.5 Strongbridge Biopharma Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Cushing’s Disease Treatment Introduction
13.4.4 Novartis Revenue in Cushing’s Disease Treatment Business (2015-2020)
13.4.5 Novartis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cushing’s Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Cushing’s Disease Treatment Revenue
Table 3. Ranking of Global Top Cushing’s Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cushing’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ketoconazole
Table 6. Key Players of Mitotane
Table 7. Key Players of Aminoglutethimide
Table 8. Key Players of Metyrapone
Table 9. Key Players of Mifepristone
Table 10. Key Players of Etomidate
Table 11. Key Players of Pasireotide
Table 12. Global Cushing’s Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Cushing’s Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Cushing’s Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Cushing’s Disease Treatment Market Share by Regions (2015-2020)
Table 16. Global Cushing’s Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Cushing’s Disease Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Cushing’s Disease Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Cushing’s Disease Treatment Players
Table 23. Global Cushing’s Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Cushing’s Disease Treatment Market Share by Players (2015-2020)
Table 25. Global Top Cushing’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cushing’s Disease Treatment as of 2019)
Table 26. Global Cushing’s Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Cushing’s Disease Treatment Product Solution and Service
Table 29. Date of Enter into Cushing’s Disease Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Cushing’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Cushing’s Disease Treatment Market Size Share by Type (2015-2020)
Table 33. Global Cushing’s Disease Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Cushing’s Disease Treatment Market Size Share by Application (2015-2020)
Table 35. Global Cushing’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Cushing’s Disease Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Cushing’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Cushing’s Disease Treatment Market Share (2019-2020)
Table 39. North America Cushing’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Cushing’s Disease Treatment Market Share by Type (2015-2020)
Table 41. North America Cushing’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Cushing’s Disease Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Cushing’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Cushing’s Disease Treatment Market Share (2019-2020)
Table 45. Europe Cushing’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Cushing’s Disease Treatment Market Share by Type (2015-2020)
Table 47. Europe Cushing’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Cushing’s Disease Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Cushing’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Cushing’s Disease Treatment Market Share (2019-2020)
Table 51. China Cushing’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Cushing’s Disease Treatment Market Share by Type (2015-2020)
Table 53. China Cushing’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Cushing’s Disease Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Cushing’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Cushing’s Disease Treatment Market Share (2019-2020)
Table 57. Japan Cushing’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Cushing’s Disease Treatment Market Share by Type (2015-2020)
Table 59. Japan Cushing’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Cushing’s Disease Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Cushing’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Cushing’s Disease Treatment Market Share (2019-2020)
Table 63. Southeast Asia Cushing’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Cushing’s Disease Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Cushing’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Cushing’s Disease Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Cushing’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Cushing’s Disease Treatment Market Share (2019-2020)
Table 69. India Cushing’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Cushing’s Disease Treatment Market Share by Type (2015-2020)
Table 71. India Cushing’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Cushing’s Disease Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Cushing’s Disease Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Cushing’s Disease Treatment Market Share (2019-2020)
Table 75. Central & South America Cushing’s Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Cushing’s Disease Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Cushing’s Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Cushing’s Disease Treatment Market Share by Application (2015-2020)
Table 79. CORCEPT THERAPEUTICS Company Details
Table 80. CORCEPT THERAPEUTICS Business Overview
Table 81. CORCEPT THERAPEUTICS Product
Table 82. CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2015-2020) (Million US$)
Table 83. CORCEPT THERAPEUTICS Recent Development
Table 84. HRA Pharma Company Details
Table 85. HRA Pharma Business Overview
Table 86. HRA Pharma Product
Table 87. HRA Pharma Revenue in Cushing’s Disease Treatment Business (2015-2020) (Million US$)
Table 88. HRA Pharma Recent Development
Table 89. Strongbridge Biopharma Company Details
Table 90. Strongbridge Biopharma Business Overview
Table 91. Strongbridge Biopharma Product
Table 92. Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2015-2020) (Million US$)
Table 93. Strongbridge Biopharma Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Product
Table 97. Novartis Revenue in Cushing’s Disease Treatment Business (2015-2020) (Million US$)
Table 98. Novartis Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cushing’s Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Ketoconazole Features
Figure 3. Mitotane Features
Figure 4. Aminoglutethimide Features
Figure 5. Metyrapone Features
Figure 6. Mifepristone Features
Figure 7. Etomidate Features
Figure 8. Pasireotide Features
Figure 9. Global Cushing’s Disease Treatment Market Share by Application: 2020 VS 2026
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Drug Stores Case Studies
Figure 13. Clinics Case Studies
Figure 14. E-Commerce/Online Pharmacies Case Studies
Figure 15. Cushing’s Disease Treatment Report Years Considered
Figure 16. Global Cushing’s Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Cushing’s Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 18. Global Cushing’s Disease Treatment Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Cushing’s Disease Treatment Market Share by Players in 2019
Figure 21. Global Top Cushing’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cushing’s Disease Treatment as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Cushing’s Disease Treatment Revenue in 2019
Figure 23. North America Cushing’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Cushing’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Cushing’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Cushing’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Cushing’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Cushing’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Cushing’s Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed
クッシング症候群治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…- クッシング症候群・先端巨大症治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly …
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- 希少神経疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Rare Neurological Disease Treatment Market The global Rare Neurological Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rare Neurological Disease Treatment Scope a…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…